Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025

Mar 171 min read

Skyhawk Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Dec 9, 20242 min read

Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers at the 66th American Society of Hematology Annual Meeting

Nov 21, 20242 min read

Skyhawk Therapeutics Presents Compelling Preclinical Data on SKY-1214 at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Oct 24, 20242 min read

Skyhawk Therapeutics to Present Preclinical Data on SKY-1214 at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Oct 16, 20242 min read

Skyhawk Therapeutics to Present Additional Positive Topline Data from Parts A and B of Phase 1 Clinical Trial of SKY-0515 at European Huntington's Disease Network and Enroll-HD 2024

Sep 11, 20243 min read

Skyhawk Therapeutics Announces Positive Topline Results of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction

Jul 9, 20244 min read

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel, Switzerland Location

Jul 1, 20242 min read

Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Haney to Executive Chairman

Jun 11, 20244 min read

Ipsen, Skyhawk ink deal worth up to $1.8B

Apr 22, 20241 min read

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

Apr 22, 20242 min read

Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D

Apr 22, 20241 min read

Skyhawk Has Advanced to Multiple Ascending Dose in it’s SKY-0515 Huntington’s Trial

Mar 25, 20242 min read

Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small

Oct 23, 20233 min read

Drugging RNA

May 17, 20231 min read

Drugging RNA with Pills : Small Molecules for a Big Frontier

Sep 6, 20221 min read

Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets

Jul 6, 20222 min read

Bill Haney’s latest startup scores deal from Sanofi its newest Big Pharma partner, with $54M upfront

Jul 6, 20223 min read

Skyhawk Therapeutics Completes New Investment Round

Sep 14, 20211 min read

Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic

Sep 14, 20213 min read